Evidence map›Paper›PMID 11967343›Full record

ArticleJournal of virology2002

Molecular evolution of human immunodeficiency virus env in humans and monkeys: similar patterns occur during natural disease progression or rapid virus passage.

Regina Hofmann-Lehmann, Josef Vlasak, Agnès-Laurence Chenine, Pei-Lin Li, Timothy W Baba, David C Montefiori, Harold M McClure, Daniel C Anderson, Ruth M Ruprecht

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Coreceptor use in nonhuman primate models of HIV infection.Journal of translational medicine · 2011
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Regina Hofmann-LehmannDepartment of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA 02115-6084, USA.
Josef Vlasak
Agnès-Laurence Chenine
Pei-Lin Li
Timothy W Baba
David C Montefiori
Harold M McClure
Daniel C Anderson
Ruth M Ruprecht
Dana-Farber Cancer Institute · USEmory University · USHarvard University · USDuke University Hospital · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
MOLECULAR EVOLUTION OF MULTIPLY DELETED SIV IN VIVOR01RR014180 · NCRR · DANA-FARBER CANCER INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 1999 to 2008
$5.8M
MECHANISMS OF ORAL SIV TRANSMISSIONR01DE012937 · NIDCR · DANA-FARBER CANCER INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 1999 to 2003
$1.5M
FETAL IMMUNOPROPHYLAXIS AGAINST A PRIMATE LENTIVIRUSR01AI034266 · NIAID · DANA-FARBER CANCER INSTITUTE · PI RUPRECHT, RUTH MARGRIT · 1994 to 2001
$1.1M
PRIMATE IMMUNOLOGY LABORATORY FOR AIDS VACCINE R&DN01AI085343 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LETVIN, NORMAN L · 1998 to 2000
$412k
NCRR NIH HHS P51 RR000165NCRR NIH HHS R01 RR014180NCRR NIH HHS RR00165NCRR NIH HHS RR14180NIAID NIH HHS AI85343NIAID NIH HHS R01 AI034266NIAID NIH HHS R01 AI34266NIDCR NIH HHS DE12937NIDCR NIH HHS R01 DE012937PHS HHS 5 K08-A101327
6 · The paper itself

Abstract

Neonatal rhesus macaque 95-3 was inoculated with nonpassaged simian-human immunodeficiency virus strain SHIV-vpu(+), which encodes env of the laboratory-adapted human immunodeficiency virus (HIV) strain IIIB and is considered nonpathogenic. CD4(+) T-cell counts dropped to <200 cells/microl within 4.6 years, and monkey 95-3 died with opportunistic infections 5.9 years postinoculation. Transfer of blood from 95-3 to two naive adult macaques resulted in high peak viral loads and rapid, persistent T-cell depletion. Progeny virus evolved in 95-3 despite high SHIV-vpu(+) neutralizing antibody titers and still used CXCR4 but, in contrast to parental SHIV-vpu(+), productively infected macrophages and resisted neutralization. Sequence analysis revealed three new potential glycosylation sites in gp120; another two were lost. Strikingly similar mutations were detected in a laboratory worker who progressed to AIDS after accidental HIV-IIIB infection (T. Beaumont et al., J. Virol. 75:2246-2252, 2001), thus supporting the SHIV-vpu(+)/rhesus macaque system as a relevant model. Similar mutations were also described after rapid passage of chimeric viruses encoding IIIB env in rhesus and pig-tailed macaques (M. Cayabyab et al., J. Virol. 73:976-984, 1999; Z. Q. Liu et al., Virology 260:295-307, 1999; S. V. Narayan et al., Virology 256:54-63, 1999; R. Raghavan et al., Brain Pathol. 7:851-861, 1997; E. B. Stephens et al., Virology 231:313-321, 1997). Thus, HIV-IIIB env evolved similarly in three different species; this selection occurred in chronically infected individuals during disease progression as well as after rapid virus passage. We postulate that evolutionary pressure led to the outgrowth of more aggressive viral variants in all three species.

Indexed as

Evolution, MolecularAmino Acid SequenceAnimalsAnimals, NewbornDisease Models, AnimalHIV-1HIV Envelope Protein gp120HIV InfectionsHumansMacaca mulattaMolecular Sequence DataMutationSequence AlignmentViral Envelope ProteinsHIV Envelope Protein gp120Viral Envelope Proteins

Identifiers

PMID11967343
PMCPMC136137
OpenAlexW2170050241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.